IFNA2 and viral infectious disease: Our data showed, compared with IFN-transformed B. longum, that IFN-α2b administered intramuscularly could reduce significantly virus infection, decrease the severity of virus-induced myocarditis, and induce a robust Th1 pattern in the spleen and heart.